Doctor profile · Federal record
Dr. Pedro Hermida de Viveiros, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Chicago, IL
- NPI 1427512847
- Accepts Medicare
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
233 E Superior St Fl 1
Chicago, IL 606112913
(312) 926-9636
fax (312) 695-1106 - Additional location
-
675 N Saint Clair St Ste 21-100
Chicago, IL 606115970
(312) 695-0990
Credentials & registration
- NPI registered
- January 2019 — 7 yrs on file
- Profile last updated
- June 4, 2024
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Illinois #036157214
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427512847. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
32,570
Distinct HCPCS
10
Medicare allowed
$1,249,077
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 9,200 | 29 | $53 | |
J9299 |
Injection, nivolumab, 1 mg | 6,040 | 13 | $30 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,220 | 18 | $47 | |
J1453 |
Injection, fosaprepitant, 1 mg | 3,450 | 18 | $0 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,540 | 31 | $45 | |
J9047 |
Injection, carfilzomib, 1 mg | 2,065 | 12 | $45 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 714 | 42 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 530 | 34 | $1 | |
J9041 |
Injection, bortezomib, 0.1 mg | 446 | 11 | $6 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 411 | 40 | $5 |
In context: peer comparison
Among 77 peers in this city , average services per provider: 870. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$61,264
Transactions
153
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SpringWorks Therapeutics, Inc. | 147 | $59,244.66 | |
| Deciphera Pharmaceuticals Inc. | 3 | $1,936.60 | |
| Janssen Biotech, Inc. | 1 | $31.90 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $31.25 | |
| Kyowa Kirin, Inc. | 1 | $19.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
12
Patients
0
Total drug cost
$46,398
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Imatinib Mesylate | Generic | 12 | 0 | $46,398 |
Hospital affiliations
Frequently asked questions
What is Dr. Pedro Hermida de Viveiros's medical specialty?
Dr. Pedro Hermida de Viveiros practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Pedro Hermida de Viveiros practice?
Dr. Pedro Hermida de Viveiros practices at 233 E Superior St Fl 1, Chicago, IL 606112913. Office phone: 3129269636.
What is Dr. Pedro Hermida de Viveiros's NPI?
Dr. Pedro Hermida de Viveiros's National Provider Identifier (NPI) is 1427512847, issued by NPPES.
Does Dr. Pedro Hermida de Viveiros accept Medicare assignment?
Yes. Dr. Pedro Hermida de Viveiros accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Pedro Hermida de Viveiros commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.